Infusion pump

Sparrow COVID-19 IV Infusion Clinic

Sparrow COVID-19 IV Infusion Treatment

The FDA has issued an Emergency Use Authorization (EUA) for the use of monoclonal antibodies to treat high-risk mild to moderate COVID-19 patients. While the safety and effectiveness of these medications continue to be evaluated, these monoclonal antibodies have shown in clinical trials to reduce COVID-19 related hospitalizations for high-risk patients. The FDA granted authorization for monoclonal antibody outpatient infusions for adult COVID-19 patients that meet very specific criteria (see below). Sparrow has established several COVID-19 IV Infusion Clinics to safely treat COVID-19 positive patients over the age of 18 in an outpatient setting.

Monoclonal antibody therapy

What are monoclonal antibodies?
Monoclonal antibodies are proteins created in a laboratory. These proteins help the immune system to fight off harmful pathogens such as viruses.

What are Casirivimab/Imdevimab?
Casirivimab/Imdevimab are monoclonal antibodies that are used to treat mild to moderate symptoms of COVID-19 in patients who are at high risk for developing severe COVID-19 symptoms or the need for hospitalization.

What is the treatment?
Casirivimab/Imdevimab are given through a vein (intravenous or IV). You will receive one dose of Casirivimab/Imdevimab by IV infusion.

How do I qualify for treatment?

Adults and adolescents age 12-17 years and weighing at least 40 kg may qualify for monoclonal antibody treatment if:

  • They have a positive COVID-19 test result with symptoms
  • The onset of COVID-19 symptoms is within the past 10 days
  • One or more of the following medical conditions or other factors are present that may place them at higher risk for progression to severe COVID-19:
    • Age ≥65 years of age
    • Being overweight
    • Pregnancy
    • Chronic kidney disease
    • Diabetes mellitus
    • Immunosuppressive disease or immunosuppressive treatment
    • Cardiovascular disease (including congenital heart disease) or hypertension
    • Chronic lung diseases (for example, chronic obstructive pulmonary disease, asthma [moderate-to-severe], interstitial lung disease, cystic fibrosis and pulmonary hypertension)
    • Sickle cell disease
    • Neurodevelopmental disorders (for example, cerebral palsy) or other conditions that confer medical complexity (for example, genetic or metabolic syndromes and severe congenital anomalies)
    • Having a medical-related technological dependence (for example, tracheostomy, gastrostomy, or positive pressure ventilation (not related to COVID-19))
  • Other medical conditions or factors not listed above are present (for example, race or ethnicity) that in the judgment of the provider may also place individual patients at high risk for progression to severe COVID-19.

How to be referred to the clinic

Patients must check with their doctor to see if they are eligible. A doctor must submit an order for a patient to be eligible. Orders can be found in EPIC, physicians can download and fax completed order form to the desired clinic location as noted on the form. 

For questions, please email COVIDtreatment@sparrow.org

Where can I learn more?

Locations

Specialty Infusion Clinic
St. Lawrence Campus
1210 W. Saginaw
Lansing, MI 48915

Office hours:
By appointment only 

 

Specialty Infusion Clinic Entrance St. Lawrence Campus Map

Sparrow Carson Hospital
406 E. Elm St.
Carson City, MI 48811

Office hours:
By appointment only 

Enter at Emergency Department

Carson City Campus 2021

Sparrow Clinton Hospital
805 S. Oakland
St. Johns, MI 48879

Office hours:
By appointment only 

Go to the North Main Entrance for screening and registration

Clinton hospital- campus

Sparrow Eaton Hospital
321 E. Harris St.
Charlotte, MI 48813

Office hours:
By appointment only

First Level

Sparrow Ionia Hospital
3565 S. State Rd.
Ionia, MI 48846

Office hours:
By appointment only

Go to ED registration after screening

Ionia Campus Map